Challenges in Colorectal Cancer
2nd Edition
Published on 8. May 2008
296 pages
978-0-470-75322-4 (ISBN)
Description
The latest guidance on challenging and controversial aspects ofcolorectal cancer
Colorectal cancer is one of the most common forms of cancer inthe US and Europe. Thousands of people are diagnosed with thedisease every year and nearly half of these die as a result. Ascolorectal cancer is curable when detected early, a significantproportion of these deaths could be prevented by earlierdiagnosis.
Much has changed since the publication of the first edition ofthis book in 2001: introduction of screening programs, improveddiagnosis and surgery for rectal cancer, and advances in adjuvantand palliative medical therapy to name but a few.
Challenges in Colorectal Cancer provides the mostup-to-date information on the new and emerging treatments. Thesecond edition looks at the total patient management of thiscondition and is aimed at the entire medical team caring for thosewith colorectal cancer. It also contains the latest guidelines onepidemiology and prevention of colorectal cancer, and theapplication of molecular genetics.
The expanded international editor team present advice onsurgical management, including new laparoscopic and endoscopictechniques and the role of the pathologist. They also review hottopics in colorectal cancer treatment, including the role ofradiotherapy, options for chemotherapy and new developments invaccines and immunotherapy.
Reviews / Votes
"The text is extremely well references and well illustrated and provides a worthwhile edition to the library of all workers in the field." Colorectal Disease, 2007 "A good book looking at the total management of patients with this condition and aimed at the entire medical team caring fro those with colorectal cancer." Digestive and Liver Disease, 2007 From a review of the first edition: "More knowledge of molecular biology, better definition of risk groups, better screening, further development of risk- oriented combination therapy, and more meticulous surgery may yield much higher cure rates for colon and rectal cancer. Scholefield's book is one of the best starting points for a journey through the world of established, new, and evolving treatments for these diseases." New England Journal of Medicine, September 2000 "Robert W Beart, Jr., states in the foreword that this book provides an "up-to-date record of the rapidly evolving alternatives" in chapters which span the gamut from prevention through palliation. It is written for subspecialist physicians, nurses, and other members of the medical team. The emphasis throughout is providing this team with concrete, useful information. Although the authors are predominantly from the U.K., European and American issues are identified throughout." (Carol Scott-Conner, MD, PhD, MBA, @Doody's Review Service)"The text is extremely well references and well illustrated andprovides a worthwhile edition to the library of all workers in thefield." Colorectal Disease, 2007 "A good book looking at the total management of patients withthis condition and aimed at the entire medical team caring frothose with colorectal cancer." Digestive and Liver Disease, 2007 From a review of the first edition: "More knowledge of molecular biology, better definitionof risk groups, better screening, further development of risk-oriented combination therapy, and more meticulous surgery may yieldmuch higher cure rates for colon and rectal cancer.Scholefield's book is one of the best starting points for ajourney through the world of established, new, and evolvingtreatments for these diseases." New England Journal of Medicine, September 2000More details
Other editions
Additional editions
John H. Scholefield | Herand Abcarian | Tim Maughan
Challenges in Colorectal Cancer Second Edition
Software
01/2008
Wiley
€95.85
No shipping information available
John H. Scholefield | Herand Abcarian | Tim Maughan
Challenges in Colorectal Cancer
Book
06/2006
2nd Edition
Wiley
€171.50
Shipment within 3-4 weeks
Persons
Professor John Scholefield is Professor of surgery atUniversity Hospital in Nottingham. He is doing research intopossible screening tests for spotting colorectal cancer early andcell changes in colorectal cancer. He chairs the National CancerResearch Institute's colorectal cancer group, and is also a memberof Council of the Association of Surgeons.
Professor Herand Abcarian MD FACS, Turi JosefsenProfessor and Chairman of the Department of Surgery, University ofIllinois College of Medicine at Chicago, USA.
Professor Tim Maughan, Professor of Cancer Studies at theUniversity of Wales, College of Medicine, and Consultant ClinicalOncologist at the Velindre Hospital Swansea. Also Chairman of theAll Wales Cancer Network.
Professor Axel Grothey, Mayo Clinic, USA (formerlyProfessor of Medicine and Oncology at Martin Luther University,Halle, Germany).
Content
List of contributors.
Foreword.
1 Richard Nelson.
Does lifestyle cause colorectal cancer?.
2 Robert Steele.
Screening for colorectal cancer - who, when, and how?.
3 Phil Quirke.
What can the pathologist tell the multidisciplinary team aboutrectal cancer resection?.
4 Brendan Morgan and John H. Scholefield.
MRI-directed rectal cancer surgery.
5 Pierre J. Guillou.
Minimally invasive surgery - where are we? Laparoscopicsurgery for cancer of the colon and rectum.
6 Theodore J. Saclarides.
Minimally invasive surgery - where are we? Is there a rolefor TEM?.
7 Seung-Yong Jeong, David Chessin, Susan Ritchie, John H.Scholefield, and Jose G. Guillem.
What is the best strategy for the management of hereditarycolorectal cancer?.
8 Rachel Cooper and David Sebag-Montefiore.
Adjuvant radiotherapy and chemoradiotherapy in the treatment ofrectal cancer.
9 George P. Kim and Axel Grothey.
Current challenges in the adjuvant therapy of colon cancer.
10 Jill Dean.
The role of the colorectal nurse specialist in the management ofcolorectal cancer.
11 Julia Jessop and Ian Daniels.
The role of the multidisciplinary team in the management ofcolorectal cancer.
12 John Northover and Chris Byrne.
Follow-up after colorectal cancer resection: Is itworthwhile?.
13 Axel Grothey.
Chemotherapy of advanced colorectal cancer.
14 Timothy G. John and Myrddin Rees.
Surgery for metastatic disease in colorectal cancer.
15 Melanie Jefferson and Ilora Finlay.
Palliative care of the colorectal cancer patient.
16 Anthony E l-Khoueiry and Heinz-Josef Lenz.
Future directions in the oncological treatment of colorectalcancer.
Index
